232 related articles for article (PubMed ID: 25656989)
1. Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas.
Li-Chang HH; Kasaian K; Ng Y; Lum A; Kong E; Lim H; Jones SJ; Huntsman DG; Schaeffer DF; Yip S
BMC Cancer; 2015 Feb; 15():32. PubMed ID: 25656989
[TBL] [Abstract][Full Text] [Related]
2. SMARCA4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach.
Neil AJ; Zhao L; Isidro RA; Srivastava A; Cleary JM; Dong F
Mod Pathol; 2023 Jun; 36(6):100183. PubMed ID: 37054973
[TBL] [Abstract][Full Text] [Related]
3. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
Kato S; Okamura R; Baumgartner JM; Patel H; Leichman L; Kelly K; Sicklick JK; Fanta PT; Lippman SM; Kurzrock R
Clin Cancer Res; 2018 Dec; 24(24):6248-6256. PubMed ID: 30348637
[TBL] [Abstract][Full Text] [Related]
5.
Klempner SJ; Madison R; Pujara V; Ross JS; Miller VA; Ali SM; Schrock AB; Kim ST; Maron SB; Dayyani F; Catenacci DVT; Lee J; Chao J
Oncologist; 2019 Nov; 24(11):1462-1468. PubMed ID: 31249137
[TBL] [Abstract][Full Text] [Related]
6. HER2 expression in gastric and gastroesophageal junction adenocarcinoma in a US population: clinicopathologic analysis with proposed approach to HER2 assessment.
Kunz PL; Mojtahed A; Fisher GA; Ford JM; Chang DT; Balise RR; Bangs CD; Cherry AM; Pai RK
Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):13-24. PubMed ID: 21617522
[TBL] [Abstract][Full Text] [Related]
7. Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing.
Yoshida T; Yamaguchi T; Maekawa S; Takano S; Kuno T; Tanaka K; Iwamoto F; Tsukui Y; Kobayashi S; Asakawa Y; Shindo H; Fukasawa M; Nakayama Y; Inoue T; Uetake T; Ohtaka M; Sato T; Mochizuki K; Enomoto N
Gastric Cancer; 2019 Jul; 22(4):742-750. PubMed ID: 30756200
[TBL] [Abstract][Full Text] [Related]
8. Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.
Geng Q; Lao J; Zuo X; Chen S; Bei JX; Xu D
J Pathol; 2020 Nov; 252(3):263-273. PubMed ID: 32715475
[TBL] [Abstract][Full Text] [Related]
9. The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.
Demicco EG; Farris AB; Baba Y; Agbor-Etang B; Bergethon K; Mandal R; Daives D; Fukuoka J; Shimizu M; Dias-Santagata D; Ogino S; Iafrate AJ; Gaissert HA; Mino-Kenudson M
Mod Pathol; 2011 Sep; 24(9):1177-90. PubMed ID: 21572404
[TBL] [Abstract][Full Text] [Related]
10. Genetic mutation analysis of human gastric adenocarcinomas using ion torrent sequencing platform.
Xu Z; Huo X; Ye H; Tang C; Nandakumar V; Lou F; Zhang D; Dong H; Sun H; Jiang S; Zhang G; Liu Z; Dong Z; Guo B; He Y; Yan C; Wang L; Su Z; Li Y; Gu D; Zhang X; Wu X; Wei X; Hong L; Zhang Y; Yang J; Gong Y; Tang C; Jones L; Huang XF; Chen SY; Chen J
PLoS One; 2014; 9(7):e100442. PubMed ID: 25025766
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status.
Wood AC; Zhang Y; Mo Q; Cen L; Fontaine J; Hoffe SE; Frakes J; Dineen SP; Pimiento JM; Walko CM; Mehta R
Oncologist; 2022 Apr; 27(4):307-313. PubMed ID: 35380714
[TBL] [Abstract][Full Text] [Related]
12. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population.
Shan L; Ying J; Lu N
Diagn Pathol; 2013 May; 8():76. PubMed ID: 23656792
[TBL] [Abstract][Full Text] [Related]
13. Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
Kwon CH; Kim YK; Lee S; Kim A; Park HJ; Choi Y; Won YJ; Park DY; Lauwers GY
Histopathology; 2018 Mar; 72(4):556-568. PubMed ID: 28873240
[TBL] [Abstract][Full Text] [Related]
14. Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System.
Huang Q; Shi J; Feng A; Fan X; Zhang L; Mashimo H; Cohen D; Lauwers G
Mod Pathol; 2011 Jan; 24(1):138-46. PubMed ID: 20852593
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis by next generation sequencing of gastric type dysplasia occurring in hyperplastic polyps of the stomach: Mutations in gastric hyperplastic polyps.
Salomao M; Luna AM; Sepulveda JL; Sepulveda AR
Exp Mol Pathol; 2015 Dec; 99(3):468-73. PubMed ID: 26325218
[TBL] [Abstract][Full Text] [Related]
16. The genomic landscape of oesophagogastric junctional adenocarcinoma.
Chong IY; Cunningham D; Barber LJ; Campbell J; Chen L; Kozarewa I; Fenwick K; Assiotis I; Guettler S; Garcia-Murillas I; Awan S; Lambros M; Starling N; Wotherspoon A; Stamp G; Gonzalez-de-Castro D; Benson M; Chau I; Hulkki S; Nohadani M; Eltahir Z; Lemnrau A; Orr N; Rao S; Lord CJ; Ashworth A
J Pathol; 2013 Nov; 231(3):301-10. PubMed ID: 24308032
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract][Full Text] [Related]
18. High-throughput mutation profiling identifies frequent somatic mutations in advanced gastric adenocarcinoma.
Lee J; van Hummelen P; Go C; Palescandolo E; Jang J; Park HY; Kang SY; Park JO; Kang WK; MacConaill L; Kim KM
PLoS One; 2012; 7(6):e38892. PubMed ID: 22723903
[TBL] [Abstract][Full Text] [Related]
19. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.
Tanner M; Hollmén M; Junttila TT; Kapanen AI; Tommola S; Soini Y; Helin H; Salo J; Joensuu H; Sihvo E; Elenius K; Isola J
Ann Oncol; 2005 Feb; 16(2):273-8. PubMed ID: 15668283
[TBL] [Abstract][Full Text] [Related]
20. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
van Beek EJAH; Hernandez JM; Goldman DA; Davis JL; McLaughlin K; Ripley RT; Kim TS; Tang LH; Hechtman JF; Zheng J; Capanu M; Schultz N; Hyman DM; Ladanyi M; Berger MF; Solit DB; Janjigian YY; Strong VE
Ann Surg Oncol; 2018 Jul; 25(7):2027-2033. PubMed ID: 29725898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]